Medical Care

Global Gene Therapies for Cancer Treatment Market Research Report 2026

This report delivers a comprehensive overview of the global Gene Therapies for Cancer Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Therapies for Cancer Treatment. The Gene Therapies for Cancer Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Therapies for Cancer Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Vectors
Non-viral Vectors
Segment by Application
Solid Tumors
Hematologic Malignancies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Therapies for Cancer Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Viral Vectors
1.2.3 Non-viral Vectors
1.3 Market by Application
1.3.1 Global Gene Therapies for Cancer Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Solid Tumors
1.3.3 Hematologic Malignancies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2021–2032)
2.2 Global Gene Therapies for Cancer Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Therapies for Cancer Treatment Historic Market Size by Region (2021–2026)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2027–2032)
2.3 Gene Therapies for Cancer Treatment Market Dynamics
2.3.1 Gene Therapies for Cancer Treatment Industry Trends
2.3.2 Gene Therapies for Cancer Treatment Market Drivers
2.3.3 Gene Therapies for Cancer Treatment Market Challenges
2.3.4 Gene Therapies for Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2021–2026)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Therapies for Cancer Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Therapies for Cancer Treatment Revenue
3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2025
3.5 Global Key Players of Gene Therapies for Cancer Treatment Head Offices and Areas Served
3.6 Global Key Players of Gene Therapies for Cancer Treatment, Products and Applications
3.7 Global Key Players of Gene Therapies for Cancer Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Therapies for Cancer Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2021–2026)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2027–2032)
5 Gene Therapies for Cancer Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2021–2026)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Therapies for Cancer Treatment Market Size (2021–2032)
6.2 North America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Therapies for Cancer Treatment Market Size by Country (2021–2026)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2021–2032)
7.2 Europe Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country (2021–2026)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2021–2032)
8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2021–2032)
9.2 Latin America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2021–2026)
9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2021–2032)
10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapies for Cancer Treatment Introduction
11.1.4 Biogen Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapies for Cancer Treatment Introduction
11.2.4 Novartis Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapies for Cancer Treatment Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapies for Cancer Treatment Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Sunway Biotech
11.5.1 Sunway Biotech Company Details
11.5.2 Sunway Biotech Business Overview
11.5.3 Sunway Biotech Gene Therapies for Cancer Treatment Introduction
11.5.4 Sunway Biotech Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.5.5 Sunway Biotech Recent Development
11.6 SIBIONO
11.6.1 SIBIONO Company Details
11.6.2 SIBIONO Business Overview
11.6.3 SIBIONO Gene Therapies for Cancer Treatment Introduction
11.6.4 SIBIONO Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.6.5 SIBIONO Recent Development
11.7 AnGes
11.7.1 AnGes Company Details
11.7.2 AnGes Business Overview
11.7.3 AnGes Gene Therapies for Cancer Treatment Introduction
11.7.4 AnGes Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.7.5 AnGes Recent Development
11.8 Orchard Therapeutics
11.8.1 Orchard Therapeutics Company Details
11.8.2 Orchard Therapeutics Business Overview
11.8.3 Orchard Therapeutics Gene Therapies for Cancer Treatment Introduction
11.8.4 Orchard Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.8.5 Orchard Therapeutics Recent Development
11.9 Human Stem Cells Institute
11.9.1 Human Stem Cells Institute Company Details
11.9.2 Human Stem Cells Institute Business Overview
11.9.3 Human Stem Cells Institute Gene Therapies for Cancer Treatment Introduction
11.9.4 Human Stem Cells Institute Revenue in Gene Therapies for Cancer Treatment Business (2021–2026)
11.9.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Viral Vectors
Table 3. Key Players of Non-viral Vectors
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million), 2021–2026
Table 7. Global Gene Therapies for Cancer Treatment Market Share by Region (2021–2026)
Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Gene Therapies for Cancer Treatment Market Share by Region (2027–2032)
Table 10. Gene Therapies for Cancer Treatment Market Trends
Table 11. Gene Therapies for Cancer Treatment Market Drivers
Table 12. Gene Therapies for Cancer Treatment Market Challenges
Table 13. Gene Therapies for Cancer Treatment Market Restraints
Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (US$ Million), 2021–2026
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2021–2026)
Table 16. Global Top Gene Therapies for Cancer Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Therapies for Cancer Treatment Revenue, 2025
Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Gene Therapies for Cancer Treatment, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapies for Cancer Treatment, Products and Applications
Table 21. Global Key Players of Gene Therapies for Cancer Treatment, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (US$ Million), 2021–2026
Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2021–2026)
Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2027–2032)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Application (US$ Million), 2021–2026
Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2021–2026)
Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2027–2032)
Table 31. North America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2021–2026
Table 33. North America Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (US$ Million), 2027–2032
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapies for Cancer Treatment Product
Table 49. Biogen Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapies for Cancer Treatment Product
Table 54. Novartis Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapies for Cancer Treatment Product
Table 59. Gilead Sciences Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapies for Cancer Treatment Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 65. Sarepta Therapeutics Recent Development
Table 66. Sunway Biotech Company Details
Table 67. Sunway Biotech Business Overview
Table 68. Sunway Biotech Gene Therapies for Cancer Treatment Product
Table 69. Sunway Biotech Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 70. Sunway Biotech Recent Development
Table 71. SIBIONO Company Details
Table 72. SIBIONO Business Overview
Table 73. SIBIONO Gene Therapies for Cancer Treatment Product
Table 74. SIBIONO Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 75. SIBIONO Recent Development
Table 76. AnGes Company Details
Table 77. AnGes Business Overview
Table 78. AnGes Gene Therapies for Cancer Treatment Product
Table 79. AnGes Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 80. AnGes Recent Development
Table 81. Orchard Therapeutics Company Details
Table 82. Orchard Therapeutics Business Overview
Table 83. Orchard Therapeutics Gene Therapies for Cancer Treatment Product
Table 84. Orchard Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 85. Orchard Therapeutics Recent Development
Table 86. Human Stem Cells Institute Company Details
Table 87. Human Stem Cells Institute Business Overview
Table 88. Human Stem Cells Institute Gene Therapies for Cancer Treatment Product
Table 89. Human Stem Cells Institute Revenue in Gene Therapies for Cancer Treatment Business (US$ Million), 2021–2026
Table 90. Human Stem Cells Institute Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. Gene Therapies for Cancer Treatment Picture
Figure 2. Global Gene Therapies for Cancer Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Therapies for Cancer Treatment Market Share by Type: 2025 vs 2032
Figure 4. Viral Vectors Features
Figure 5. Non-viral Vectors Features
Figure 6. Global Gene Therapies for Cancer Treatment Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Gene Therapies for Cancer Treatment Market Share by Application: 2025 vs 2032
Figure 8. Solid Tumors Case Studies
Figure 9. Hematologic Malignancies Case Studies
Figure 10. Gene Therapies for Cancer Treatment Report Years Considered
Figure 11. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Gene Therapies for Cancer Treatment Market Share by Region: 2025 vs 2032
Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2025
Figure 15. Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2025
Figure 17. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Gene Therapies for Cancer Treatment Market Share by Country (2021–2032)
Figure 19. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Gene Therapies for Cancer Treatment Market Share by Country (2021–2032)
Figure 23. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2021–2032)
Figure 31. China Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2021–2032)
Figure 39. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2021–2032)
Figure 43. Israel Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Biogen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 47. Novartis Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 48. Gilead Sciences Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 49. Sarepta Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 50. Sunway Biotech Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 51. SIBIONO Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 52. AnGes Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 53. Orchard Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 54. Human Stem Cells Institute Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2021–2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies